What is the 13F Pro Quality Score for NTHI?

13F Pro ranks NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NTHI's current score at https://13fpro.ai/company/NTHI (free sign-up required for the full ranking).

Where does 13F Pro source NTHI data?

All NEONC TECHNOLOGIES HOLDINGS, INC. fundamentals and ownership data come directly from SEC EDGAR. NEONC TECHNOLOGIES HOLDINGS, INC. files with the SEC under CIK 1979414. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NTHI in?

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is NTHI research updated on 13F Pro?

NTHI's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

NEONC TECHNOLOGIES HOLDINGS, INC.(NTHI)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1979414 NTHI stock profile & AI dashboard →

13F Pro Quality Score

18.0/100

Rank #2,814 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why NTHI Scores 18/100

exact factor attribution · 2026-09-11

NTHI's composite is held back by profitability and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

-0.4 pts

46th pct

Earnings growth

-1.0 pts

30th pct

Institutional flow

-1.3 pts

25th pct

Shareholder dilution

-2.5 pts

0th pct

Scale

-3.0 pts

30th pct

Revenue growth

-4.0 pts

30th pct

Capital efficiency

-5.0 pts

0th pct

Free cash flow

-7.4 pts

0th pct

Profitability

-7.5 pts

0th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

Unusual Activity in NTHI

Events flagged as statistical outliers against NTHI's own multi-year baseline — not fixed dollar thresholds.

Insider cluster2026-08-18
2 insiders bought $248,440 of NTHI in 30 days — 3.7σ above this company's 2-year norm
View source filing →

NTHI Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NTHI at 18.0/100 on a 32-signal composite quality model, placing it at rank #2,814 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of NTHI by reported 13-F value include Cinctive Capital Management, VANGUARD CAPITAL MANAGEMENT, BANK OF AMERICA, based on the most recent SEC filings. NTHI trades on the Nasdaq exchange and files with the SEC under CIK 1979414. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NTHI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEONC TECHNOLOGIES HOLDINGS, INC. directly from SEC EDGAR. NEONC TECHNOLOGIES HOLDINGS, INC.'s 13F Pro composite quality score has ranged between 8 and 26 since 2026, currently 18.0 — a declining long-term trajectory across 8 quarterly and live scoring snapshots.

✦

Fun facts about NEONC TECHNOLOGIES HOLDINGS, INC.

Quirks, history, and lore behind NTHI — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare technology company · listed on Nasdaq · focused on cancer treatment · headquartered in California.
2
The Numbers
A small-cap clinical-stage company with limited revenue — the kind of balance sheet where the pipeline IS the business model.
3
The History
Founded in the 2010s, it set out to commercialize proton therapy technology, a highly precise form of radiation that spares healthy tissue around tumors.
4
The Secret
Its core pitch is making proton therapy systems smaller, cheaper, and more accessible — the traditional systems cost hundreds of millions and fill an entire hospital wing.
5
The Lore
The company's name is literally a nod to its mission: neo + oncology, signaling a new era in fighting cancer with particle beams instead of conventional X-rays.
6
The Giveaway
Ticker NTHI, developing a compact proton therapy system — because shrinking a particle accelerator into something a community hospital can afford is apparently a reasonable business plan.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$0.00

Net Income

Q2 2026

$-14.2M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-51.8% YoY

$40.0KFY 2025

FY23 —FY24 $83.0KFY25 $40.0K

Net Income

-422.3% YoY

$-62.1MFY 2025

FY23 —FY24 $-11.9MFY25 $-62.1M

Operating Income

-715.4% YoY

$-58.2MFY 2025

FY23 —FY24 $-7.1MFY25 $-58.2M

EPS (Diluted)

-363.8% YoY

$-3.20FY 2025

FY23 —FY24 $-0.69FY25 $-3.20

Total Assets

-17.4% YoY

$2.8MFY 2025

FY23 —FY24 $3.4MFY25 $2.8M

Op. Cash Flow

-383.3% YoY

$-20.4MFY 2025

FY23 —FY24 $-4.2MFY25 $-20.4M

Free Cash Flow

$-20.9MFY 2025

FY23 —FY24 —FY25 $-20.9M

Metric	FY 2025	FY 2024	FY 2023
Revenue	$40.0K -51.8%	$83.0K	—
Net Income	$-62.1M -422.3%	$-11.9M	—
Operating Income	$-58.2M -715.4%	$-7.1M	—
EPS (Diluted)	$-3.20 -363.8%	$-0.69	—
Total Assets	$2.8M -17.4%	$3.4M	—
Operating Cash Flow	$-20.4M -383.3%	$-4.2M	—
Free Cash Flow	$-20.9M	—	—

Get alerted when NTHI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NEONC TECHNOLOGIES HOLDINGS, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NTHI

Cinctive Capital Management LP
$7.3M1,607,464 sh
VANGUARD CAPITAL MANAGEMENT LLC
$2.3M504,171 sh
BANK OF AMERICA CORP /DE/
$1.0M224,412 sh
Westmount Partners, LLC
$893.2K197,178 sh
BlackRock, Inc.
$814.7K179,850 sh
GEODE CAPITAL MANAGEMENT, LLC
$752.8K166,120 sh
VANGUARD FIDUCIARY TRUST CO
$414.4K91,480 sh
STATE STREET CORP
$195.6K43,170 sh
NORTHERN TRUST CORP
$162.5K35,871 sh
Global Retirement Partners, LLC
$125.9K27,790 sh

Fund	Value	Shares
Cinctive Capital Management LP	$7.3M	1,607,464
VANGUARD CAPITAL MANAGEMENT LLC	$2.3M	504,171
BANK OF AMERICA CORP /DE/	$1.0M	224,412
Westmount Partners, LLC	$893.2K	197,178
BlackRock, Inc.	$814.7K	179,850
GEODE CAPITAL MANAGEMENT, LLC	$752.8K	166,120
VANGUARD FIDUCIARY TRUST CO	$414.4K	91,480
STATE STREET CORP	$195.6K	43,170
NORTHERN TRUST CORP	$162.5K	35,871
Global Retirement Partners, LLC	$125.9K	27,790

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put NTHI on your watchlist

Track score changes the day NEONC TECHNOLOGIES HOLDINGS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NTHI a good stock to buy?

13F Pro's AI-powered analysis of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NTHI are available on the NTHI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NTHI is classified as a small company.

Which hedge funds own NTHI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NTHI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NEONC TECHNOLOGIES HOLDINGS, INC.'s investment landscape.